Global Search | Novartis United States of America

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 828 results

Media Release / Aug 17, 2004

2004 Release
Media Release / Jun 11, 2015

Novartis presents new data at WCD that shows significant efficacy of Cosentyx® in patients with psoriasis of the palms, soles of feet and nails
Media Release / Jun 01, 2015

Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma
Media Release / May 31, 2015

Combination of Novartis drugs Tafinlar® and Mekinist® shows significant survival benefit in patients with metastatic melanoma
Media Release / May 20, 2015

Novartis investigational dual bronchodilator significantly improved lung function compared to single bronchodilators in patients with moderate-to-severe COPD in phase III studies
Media Release / Mar 30, 2015

Novartis announces FDA approval for Jadenu™ to simplify treatment administration for patients with chronic iron overload
Media Release / Mar 21, 2015

Novartis presents Cosentyx™ two-year efficacy and safety data showing sustainable effect in psoriasis patients
Media Release / Mar 20, 2015

New Novartis data show more Cosentyx™-treated psoriasis patients achieved clear or almost clear skin (PASI 90) compared to Stelara®
Q&A: Answering your questions about PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) supply
Story / May 12, 2021

At-home app helps patients stay engaged and adherent to vision monitoring remotely

Education and Awareness

Novartis begins U.S. pilot program for OdySight, a clinically tested mobile application designed to help monitor vision remotely.

‹ Previous page
1
…
46
47
48
49
50
51
52
…
83
› Next page